Search Results

There are 24333 results for: content related to: Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

  1. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  2. You have full text access to this OnlineOpen article
    Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1502–1511, Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, Marie-Justine Paillard, Stefano Kim, Martin Demarchi, Francine Fein, Christophe Borg, Franck Bonnetain and Xavier Pivot

    Version of Record online : 11 AUG 2014, DOI: 10.1002/cam4.299

  3. You have free access to this content
    Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

    Cancer

    Volume 98, Issue 12, 15 December 2003, Pages: 2664–2670, Julien Taïeb, Luminita Bonyhay, Lamia Golli, Michel Ducreux, Emmanuel Boleslawski, Jean-Marie Tigaud, Thierry de Baere, Touraj Mansourbakht, Marie Anna Delgado, Laureut Hannoun, Thierry Poynard and Valerie Boige

    Version of Record online : 10 NOV 2003, DOI: 10.1002/cncr.11869

  4. Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice

    Cancer

    Volume 121, Issue 19, October 1, 2015, Pages: 3428–3434, Anne-Sophie Dussol, Marie-Odile Joly, Cecile Vercherat, Julien Forestier, Valérie Hervieu, Jean-Yves Scoazec, Catherine Lombard-Bohas and Thomas Walter

    Version of Record online : 8 JUN 2015, DOI: 10.1002/cncr.29517

  5. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

    British Journal of Haematology

    Volume 174, Issue 6, September 2016, Pages: 899–910, Antònia Obrador-Hevia, Margalida Serra-Sitjar, José Rodríguez, Lamiae Belayachi, Leyre Bento, Marta García-Recio, Jose María Sánchez, Priam Villalonga, Antonio Gutiérrez and Silvia Fernández de Mattos

    Version of Record online : 25 MAY 2016, DOI: 10.1111/bjh.14141

  6. The role of oxaliplatin in the management of upper gastrointestinal tract malignancies

    Colorectal Disease

    Volume 5, Issue s3, November 2003, Pages: 36–44, W. Scheithauer and E. Van Cutsem

    Version of Record online : 30 OCT 2003, DOI: 10.1046/j.1463-1318.5.s3.5.x

  7. You have free access to this content
    Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate

    British Journal of Clinical Pharmacology

    Volume 65, Issue 3, March 2008, Pages: 326–333, Xuemin Jiang, Peter Galettis, Matthew Links, Paul L. Mitchell and Andrew J. McLachlan

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1365-2125.2007.03040.x

  8. You have free access to this content
    Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas

    Cancer

    Volume 115, Issue 15, 1 August 2009, Pages: 3392–3399, Philippe A. Cassier, Thomas Walter, Beatrice Eymard, Philippe Ardisson, Maurice Perol, Carole Paillet, Jean-Alain Chayvialle, Jean-Yves Scoazec, Valerie Hervieu and Catherine Lombard Bohas

    Version of Record online : 26 MAY 2009, DOI: 10.1002/cncr.24384

  9. Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer

    Journal of Gastroenterology and Hepatology

    Volume 21, Issue 5, May 2006, Pages: 874–879, HUI-JU CH’ANG, CHUAN-CHENG WANG, ANN-LII CHENG, CHIUN HSU, YEN-SHEN LU, MING-CHU CHANG, JAW-TOWN LIN, HSIU-PO WANG, HER-SHYONG SHIAH, TSANG-WU LIU, JANG-YANG CHANG, JACQUELINE WHANG-PENG and LI-TZONG CHEN

    Version of Record online : 8 SEP 2005, DOI: 10.1111/j.1440-1746.2005.04022.x

  10. Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue 4, December 2011, Pages: 376–384, Paul L MITCHELL, Adam BROAD, Mark A ROSENTHAL, Peter GALETTIS, Rick ABRAHAM, Ivon BURNS, Stephen CLARKE, Alvin MILNER, Juliana DIIULIO and Matthew LINKS

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1743-7563.2011.01390.x

  11. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 359–366, P. HARNETT, M. BUCK, P. BEALE, A. GOLDRICK, S. ALLAN, B. FITZHARRIS, P. De SOUZA, M. LINKS, G. KALIMI, T. DAVIES and R. STUART-HARRIS

    Version of Record online : 11 JAN 2007, DOI: 10.1111/j.1525-1438.2007.00763.x

  12. You have free access to this content
    Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 277–284, Francesco Leone, Marco Gatti, Paolo Massucco, Federica Colombi, Elisa Sperti, Delia Campanella, Daniele Regge, Pietro Gabriele, Lorenzo Capussotti and Massimo Aglietta

    Version of Record online : 6 JUL 2012, DOI: 10.1002/cncr.27736

  13. Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

    Cancer

    Volume 122, Issue 4, February 15, 2016, Pages: 574–581, Francesco Leone, Donatella Marino, Stefano Cereda, Roberto Filippi, Carmen Belli, Rosella Spadi, Guglielmo Nasti, Massimo Montano, Alessio Amatu, Giuseppe Aprile, Celeste Cagnazzo, Gianpiero Fasola, Salvatore Siena, Libero Ciuffreda, Michele Reni and Massimo Aglietta

    Version of Record online : 5 NOV 2015, DOI: 10.1002/cncr.29778

  14. Gemcitabine–Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients

    The Breast Journal

    Volume 13, Issue 2, March/April 2007, Pages: 165–171, Thibaut Caruba, Paul-Henri Cottu, Isabelle Madelaine-Chambrin, Marc Espié, Jean-Louis Misset and Marine Gross-Goupil

    Version of Record online : 20 FEB 2007, DOI: 10.1111/j.1524-4741.2007.00391.x

  15. You have free access to this content
    Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

    Cancer

    Volume 112, Issue 12, 15 June 2008, Pages: 2733–2739, Amani Asnacios, Laetitia Fartoux, Olivier Romano, Chloe Tesmoingt, Samy Louafi S, Touraj Mansoubakht, Pascal Artru, Thierry Poynard, Olivier Rosmorduc, Mohamed Hebbar and Julien Taieb

    Version of Record online : 15 APR 2008, DOI: 10.1002/cncr.23489

  16. You have free access to this content
    Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site

    Cancer

    Volume 116, Issue 10, 15 May 2010, Pages: 2448–2454, John D. Hainsworth, David R. Spigel, Howard A. Burris III, Dianna Shipley, Cindy Farley, Ines M. Macias-Perez, John Barton and F. Anthony Greco

    Version of Record online : 5 MAR 2010, DOI: 10.1002/cncr.25029

  17. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 784–794, E. Alvarez-Cuesta, R. Madrigal-Burgaleta, D. Angel-Pereira, A. Ureña-Tavera, M. Zamora-Verduga, P. Lopez-Gonzalez and M. P. Berges-Gimeno

    Version of Record online : 24 APR 2015, DOI: 10.1111/all.12620

  18. You have free access to this content
    First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 348–355, Liang Wang, Zhi-hui Wang, Xiao-qin Chen, Ya-jun Li, Ke-feng Wang, Yun-fei Xia and Zhong-jun Xia

    Version of Record online : 18 JUL 2012, DOI: 10.1002/cncr.27752

  19. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  20. You have free access to this content
    Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

    Cancer

    Volume 113, Issue 8, 15 October 2008, Pages: 2046–2052, Henry Q. Xiong, Gauri R. Varadhachary, Joan C. Blais, Kenneth R. Hess, James L. Abbruzzese and Robert A. Wolff

    Version of Record online : 28 AUG 2008, DOI: 10.1002/cncr.23810